Medtech Insights

The launch and increasing adoption of new devices that allow treatment of more complex aneurysms will drive expansion in the European market for aortic repair devices over the forecast period…

The European market for patient monitoring devices is growing, driven by a focus on preventive care and the rising number of ambulatory surgeries. Noninvasive hemodynamic monitoring devices are…

The European EP mapping and ablation device market will experience strong growth through 2033, driven by the increasing prevalence of cardiac arrhythmia in Europe, improved access to treatment,…

The Asia Pacific EP mapping and ablation device market will experience strong growth through 2033, driven by the increasing prevalence of cardiac arrhythmia in Asia Pacific countries, improved…

The Latin American spinal implant market is set to expand over the forecast period, driven by factors such as an aging population, improved reimbursement policies, and strategic mergers and…

The European heart valve device market will continue to experience moderate growth, largely driven by the new product launches and the rapid adoption of THV devices. Positive clinical outcomes…

The European neurostimulation market will grow modestly through 2033. Growth in this market is largely driven by product innovations, particularly in the SCS and DBS segments, and iterative…

The Asia Pacific interventional oncology device market will see strong growth through 2033, driven by large and rapidly expanding patient population, increasing popularity of minimally invasive…

The European pain management space remains active, with manufacturers continuing to innovate and work toward receiving regulatory approval for new indications, supporting market growth in Europe…

The European gynecological device market will see marginal growth over the forecast period. This growth will be driven by the continued adoption of technologies that enable treatments in office-…

The Asia Pacific heart valve device market will continue to experience rapid growth, largely driven by the adoption of THV devices. Positive clinical outcomes supporting THV devices and the…

The European interventional oncology device market will see modest growth through 2033, driven by increasing incidence and prevalence rates of cancer, cost-effectiveness of ablation and…